Healthcare Industry News: vascular embolization
News Release - February 5, 2014
Reverse Medical(R) Corporation Announces New Patent for the Micro Vascular Plug (MVP(R))IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Reverse Medical Corporation announced today that the United States Patent Office has notified the Company that a new patent has issued entitled “Embolic Implant and Method of Use”. This new patent allows twenty-two claims surrounding the Company’s Micro Vascular Plug (“MVP”) technology platform.
This newly issued patent builds upon Reverse’s intellectual property portfolio, which now includes six issued patents and thirteen additional pending patent applications worldwide. Commenting on this new patent, Reverse Medical Chief Technology Officer Brian Strauss said, “This patent solidifies our intellectual property foundation of unique means for performing endovascular embolization and, along with our other issued patents and pending applications, provides us with broad protection for our innovative portfolio of devices for treating a variety of Neuro and Peripheral vascular conditions.”
Reverse Medical Corporation is a privately held medical device company focused on expanding a technology driven pipeline of innovative, state-of-the-art endovascular treatments for a broad spectrum of peripheral and neurovascular disorders and diseases. The company is based in Irvine, California.
Source: Reverse Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.